Search

everythinglearnresearchcommunity

for

Search:↓

Valproate can cause brain swelling with high ammonia levels, possibly underreported, especially in psychiatric patients.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Valproic acid helped hair growth in alopecia patient; more research needed.

Surgical grafting may fix nail issues caused by valproic acid.

The study created a new hair loss treatment paste that regrows hair faster and with fewer side effects than minoxidil alone.

Vitamin E can reduce the negative effects of valproic acid on hair and skin development.

Valproic acid, a common antiepileptic medication, can cause reversible hair loss in patients.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Sodium valproate is effective in treating epilepsy, especially in patients who don't respond to other medications.

Valproic acid may cause temporary hair changes like loss or thinning in children.

Biotin supplements did not significantly reduce hair loss in rats on valproic acid.

Topical Valproic acid and 5% Minoxidil both significantly increase hair count in Female Pattern Hair Loss, with similar side effects.

Applying valproic acid on the scalp increased hair growth in men with hair loss.

Genetic factors may influence how well valproic acid works and its side effects in epilepsy treatment.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

The 532 nm laser effectively reduces facial vascular and pigmented lesions, with the VISIA system reliably assessing treatment results.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

SVF and PRP improve hair loss, but SVF causes more side effects.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

RCVS should be considered in thunderclap headaches, and MRA and DSA are better for diagnosis than CT angiogram.

Certain gene variations are found in people with polycystic ovary syndrome.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.